Achieve Life Sciences, Inc. (ACHV) stock
Close on Nov 6, 2026Market cap $691.51MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026
Valuation
- Market cap
- $691.51M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 3.83
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$111.71M
- EPS, diluted
- -$1.37
- Free cash flow
- -$49.47M
- Book value per share
- $1.71
- Diluted shares
- 105M
Trading
- Next earnings
- Mar 23, 2027 (estimated, before the open)
- Previous close
- $6.38
- Open
- $6.50
- Day's range
- $6.25 – $6.75
- Volume
- 1,075,731
- Average volume (20 days)
- 1,350,075
- Index membership
- Russell 2000 (since Jun 2026)
- Beta (5 years)
- 1.74
- 52-week range
- $2.62 – $8.64
- RSI (14 days)
- 46.9
- Volatility (1 year)
- 81.0%
- Relative volume
- 0.74×
- WACC
- 13.6%
On 2 of our idea lists: Institutions accumulating, Most shorted (a warning list)
Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 6, 2026. The S&P 500 is measured by the SPY fund.
| Period | ACHV | S&P 500 | Difference | ACHV per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -4.4% | -5.6% | +1.2 pts | ||
| 3 months | +2.6% | -4.1% | +6.7 pts | ||
| Year to date | +35.2% | +8.7% | +26.5 pts | ||
| 1 year | +41.8% | +10.9% | +30.9 pts | ||
| 3 years | +60.8% | +75.0% | −14.2 pts | +17.1% | +20.5% |
| 5 years | -22.0% | +67.8% | −89.8 pts | -4.9% | +10.9% |
| 10 years | -99.2% | +312.9% | −412.1 pts | -38.4% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Net income
EPS, diluted
Free cash flow
Press releases
Releases Achieve Life Sciences filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
About Achieve Life Sciences
In Vitro & In Vivo Diagnostic Substances
Achieve Life Sciences, Inc. is a late-stage clinical specialty pharmaceutical company focused on the development and commercialization of cytisinicline. Its efforts center on addressing nicotine dependence by targeting adult combustible cigarette smoking and e-cigarette usage. Cytisinicline constitutes the organization's sole product candidate, developed to aid individuals seeking treatment for tobacco and nicotine addiction across the broader smoking cessation landscape.
Company profile, executives and historyAchieve Life Sciences stock: common questions
What is Achieve Life Sciences's stock price?
ACHV closed at $6.72 on Nov 6, 2026, up 5.33% on the day. Over the past 52 weeks it traded between $2.62 and $8.64.
What is Achieve Life Sciences's market cap?
Achieve Life Sciences was worth $691.51M at the close on Nov 6, 2026: the share price times the diluted shares outstanding.
What is ACHV's P/E ratio?
Achieve Life Sciences lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.37), so it has no meaningful P/E ratio.
Does Achieve Life Sciences pay a dividend?
No. Achieve Life Sciences has not paid a cash dividend over the last twelve months.
When does Achieve Life Sciences report earnings next?
Achieve Life Sciences is expected to report Q4 FY2026 results on Mar 23, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has ACHV stock performed over the past year?
Including dividends, ACHV returned +41.8% over the past year, against +10.9% for the S&P 500.
How many ACHV shares are sold short?
18M shares were sold short at the latest FINRA report, 23.47% of the float, or 13.6 days of average trading volume.
Who are Achieve Life Sciences's competitors?
Companies most similar to Achieve Life Sciences by business, industry and size include NYMXF, QCLS, QDEL, TRIB, LNTH.
See a number that looks wrong?